Global Quadrivalent Meningococcal Vaccine Supply, Demand and Key Producers, 2023-2029

Global Quadrivalent Meningococcal Vaccine Supply, Demand and Key Producers, 2023-2029

The global Quadrivalent Meningococcal Vaccine market size is expected to reach $ 279.3 million by 2029, rising at a market growth of 5.6% CAGR during the forecast period (2023-2029).

Many countries have implemented meningococcal vaccination programs, especially targeting high-risk groups such as infants, adolescents and university students. Inclusion or recommendation of quadrivalent meningococcal vaccines in national immunization schedules can significantly influence the market demand.

The meningococcal quadrivalent vaccine protects against 4 types of meningococcus: types A, C, Y, and W.

This report studies the global Quadrivalent Meningococcal Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Quadrivalent Meningococcal Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Quadrivalent Meningococcal Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Quadrivalent Meningococcal Vaccine total production and demand, 2018-2029, (K Units)

Global Quadrivalent Meningococcal Vaccine total production value, 2018-2029, (USD Million)

Global Quadrivalent Meningococcal Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Quadrivalent Meningococcal Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Quadrivalent Meningococcal Vaccine domestic production, consumption, key domestic manufacturers and share

Global Quadrivalent Meningococcal Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Quadrivalent Meningococcal Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Quadrivalent Meningococcal Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Quadrivalent Meningococcal Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi-Pasteur, Walvax, Chengdu Kanghua Biological Products Co., Ltd., Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd., Zhejiang Tianyuan Biopharmaceutical Co., Ltd., Beijing Institute of Biological Products Co., Ltd., CanSino Biological Co., Ltd., Hualan Biological Vaccine Co., Ltd. and Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Quadrivalent Meningococcal Vaccine market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Quadrivalent Meningococcal Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Quadrivalent Meningococcal Vaccine Market, Segmentation by Type
Polysaccharide Vaccine
Conjugate Vaccine

Global Quadrivalent Meningococcal Vaccine Market, Segmentation by Application
Hospital
Clinic

Companies Profiled:
Sanofi-Pasteur
Walvax
Chengdu Kanghua Biological Products Co., Ltd.
Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
Beijing Institute of Biological Products Co., Ltd.
CanSino Biological Co., Ltd.
Hualan Biological Vaccine Co., Ltd.
Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.

Key Questions Answered

1. How big is the global Quadrivalent Meningococcal Vaccine market?

2. What is the demand of the global Quadrivalent Meningococcal Vaccine market?

3. What is the year over year growth of the global Quadrivalent Meningococcal Vaccine market?

4. What is the production and production value of the global Quadrivalent Meningococcal Vaccine market?

5. Who are the key producers in the global Quadrivalent Meningococcal Vaccine market?

6. What are the growth factors driving the market demand?